- Home
- DTST vs PMN Comparison
DTST vs PMN Comparison
Compare DTST & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- PMN
- Stock Information
- Founded
- DTST 2001
- PMN 2004
- Country
- DTST United States
- PMN Canada
- Employees
- DTST N/A
- PMN N/A
- Industry
- DTST EDP Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- DTST Technology
- PMN Health Care
- Exchange
- DTST Nasdaq
- PMN Nasdaq
- Market Cap
- DTST 28.2M
- PMN 17.0M
- IPO Year
- DTST N/A
- PMN N/A
- Fundamental
- Price
- DTST $3.58
- PMN $0.45
- Analyst Decision
- DTST
- PMN Strong Buy
- Analyst Count
- DTST 0
- PMN 2
- Target Price
- DTST N/A
- PMN $4.50
- AVG Volume (30 Days)
- DTST 33.2K
- PMN 49.4K
- Earning Date
- DTST 08-13-2025
- PMN 08-07-2025
- Dividend Yield
- DTST N/A
- PMN N/A
- EPS Growth
- DTST N/A
- PMN N/A
- EPS
- DTST 0.02
- PMN N/A
- Revenue
- DTST $25,219,312.00
- PMN N/A
- Revenue This Year
- DTST $12.57
- PMN N/A
- Revenue Next Year
- DTST $9.29
- PMN N/A
- P/E Ratio
- DTST $150.68
- PMN N/A
- Revenue Growth
- DTST N/A
- PMN N/A
- 52 Week Low
- DTST $2.93
- PMN $0.43
- 52 Week High
- DTST $6.94
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- DTST 51.33
- PMN 38.45
- Support Level
- DTST $3.33
- PMN $0.48
- Resistance Level
- DTST $3.48
- PMN $0.50
- Average True Range (ATR)
- DTST 0.15
- PMN 0.03
- MACD
- DTST 0.02
- PMN -0.00
- Stochastic Oscillator
- DTST 57.89
- PMN 15.44
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.